Can cefuroxime (Cefuroxime axetil) be used to treat a urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Cefuroxime Be Used for UTI?

Yes, cefuroxime can be used for UTIs, but it is considered a second-line agent that should only be used when first-line antibiotics cannot be used. 1

Position in Treatment Guidelines

Cefuroxime, like other β-lactam cephalosporins, has inferior efficacy compared to first-line agents and causes more adverse effects than other UTI antimicrobials. 1 The Infectious Diseases Society of America classifies β-lactams as appropriate choices only when other recommended agents cannot be used. 1

First-Line Agents to Consider Before Cefuroxime

  • Nitrofurantoin is recommended as a first-choice option for uncomplicated cystitis 1
  • Amoxicillin-clavulanic acid is recommended as a first-choice option for uncomplicated cystitis 1
  • Sulfamethoxazole-trimethoprim is recommended if local resistance is less than 20% 1
  • Ciprofloxacin is recommended for mild to moderate pyelonephritis if local resistance is less than 10% 1

When Cefuroxime May Be Appropriate

Cefuroxime may be considered when:

  • First-line agents are contraindicated or unavailable 1
  • The causative organism is confirmed susceptible to cefuroxime 2
  • For uncomplicated UTIs when other recommended agents cannot be used 1

FDA-Approved Dosing for UTI

According to the FDA label, for uncomplicated urinary tract infections, 750 mg every 8 hours is recommended (parenteral formulation). 2 For oral cefuroxime axetil, 125 mg twice daily has been shown to be effective for some urinary tract infections, while 250 mg twice daily is appropriate for most infections. 3

Clinical Evidence Supporting Use

  • In clinical trials, cefuroxime achieved 80.3% bacteriological cure rates in acute uncomplicated lower UTIs when given as 125 mg twice daily for 3 days 4
  • Cefuroxime demonstrated 97% clinical success rates (cure plus improvement) in uncomplicated UTIs at 250 mg twice daily 5
  • Cefuroxime showed activity against 90.2% of gram-negative organisms in complicated UTIs 6

Important Caveats and Limitations

  • Cefuroxime is NOT effective against Pseudomonas - antipseudomonal agents like ceftazidime-avibactam or aminoglycosides are required for Pseudomonas UTIs 7
  • Cefuroxime is NOT effective against enterococci 6
  • β-lactam antibiotics like cefuroxime may promote more rapid recurrence of UTI 1
  • Cephalosporins are more likely to alter fecal microbiota and cause collateral damage compared to first-line agents 1

Antimicrobial Stewardship Considerations

For complicated UTIs caused by third-generation cephalosporin-resistant Enterobacteriaceae (3GCephRE), cotrimoxazole may be considered for non-severe complicated UTI as good practice. 8 However, for severe infections, carbapenems are recommended. 8

Always obtain urine culture before starting antibiotics for suspected pyelonephritis or complicated UTIs to guide targeted therapy. 1

References

Guideline

Cefdinir for Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cefuroxime axetil.

International journal of antimicrobial agents, 1994

Guideline

Cefdinir Ineffectiveness for Pseudomonas UTIs

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.